Gold nanoparticles as a potential carrier for transmucosal vaccine delivery

Journal of Biomedical Nanotechnology

Volumn 7, Issue 1, 2011, Pages 57-59

  Pokharkar, Varsha ^a   Bhumkar, Devika ^a   Suresh, K ^b   Shinde, Y ^b   Gairola, S ^b   Jadhav, S S ^b  

^a BHARATI VIDYAPEETH UNIVERSITY   (India)

^b Serum Institute of India Ltd   (India)

Author keywords

Chitosan; Gold nanoparticles; Tetanus toxoid; Transmucosal delivery; Vaccine

Indexed keywords

ACTIVE SITE; CHITOSAN NANOPARTICLES; DELIVERY SYSTEMS; GOLD NANOPARTICLE; GOLD NANOPARTICLES; IMMUNE RESPONSE; NANOPARTICULATE SYSTEM; ORAL ADMINISTRATION; SYSTEMIC RESPONSE; TETANUS TOXOID; TRANSMUCOSAL DELIVERY; VACCINE DELIVERY;

CHITOSAN; GOLD; NANOPARTICLES;

VACCINES;

CHITOSAN; DRUG CARRIER; GOLD NANOPARTICLE; TETANUS TOXOID; GOLD; NANOCAPSULE;

ARTICLE; CROSS LINKING; DRUG DELIVERY SYSTEM; DRUG SYNTHESIS; IMMUNE RESPONSE; IN VIVO STUDY; MOUSE; NONHUMAN; ANIMAL; CHEMISTRY; DRUG EFFECT; FEASIBILITY STUDY; IMMUNOLOGY; INTESTINE MUCOSA; MATERIALS TESTING; MUCOSAL ADMINISTRATION;

ADMINISTRATION, MUCOSAL; ANIMALS; FEASIBILITY STUDIES; GOLD; INTESTINAL MUCOSA; MATERIALS TESTING; MICE; NANOCAPSULES; TETANUS TOXOID;

EID: 79957701736     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2011.1200     Document Type: Article

References (3)

1. J. Mestecky, Z. Moldoveanu, S. M. Michalek, C. D. Morrow, R. W. Compans, D. P. Schafer, and M. W. Russell, Current options for vaccine delivery systems by mucosal routes. J. Cont. Rel. 48, 243 (1997).
2. J. Mestecky, The common mucosal immune system and current strategies for induction of immune responses in external secretions. J. Clin. Immunol. 148, 265 (1987).
3. D. R. Bhumkar, H. M. Joshi, V. B. Pokharkar, and M. Sastry, Chitosan reduced gold nanoparticles as novel carriers for transmucosal delivery of insulin. Pharm. Res. 24, 1415 (2007).